We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUM
3126
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2.05M ﹤0.01%
79,584
+10,120
+15% +$282K
AU icon
3127
CALL
AngloGold Ashanti
AU
$44.3B
$2.05M ﹤0.01%
+250,000
New +$2.19M
FFBC icon
3128
First Financial Bancorp
FFBC
$3.55B
$2.05M ﹤0.01%
66,852
+41,837
+167% +$1.31M
PRSP
3129
DELISTED
Perspecta Inc. Common Stock
PRSP
$2.05M ﹤0.01%
+99,652
New +$2.23M
RDY icon
3130
Dr. Reddy's Laboratories
RDY
$10.1B
$2.05M ﹤0.01%
317,890
+18,735
+6% +$118K
MIY icon
3131
BlackRock MuniYield Michigan Quality Fund
MIY
$351M
$2.05M ﹤0.01%
156,091
+475
+0.3% +$6.23K
BLMN icon
3132
Bloomin' Brands
BLMN
$931M
$2.04M ﹤0.01%
101,761
+85,105
+511% +$1.93M
DBE icon
3133
Invesco DB Energy Fund
DBE
$85.7M
$2.04M ﹤0.01%
119,759
-512
-0.4% -$8.33K
TECD
3134
DELISTED
Tech Data Corp
TECD
$2.04M ﹤0.01%
24,900
+5,833
+31% +$480K
JPI
3135
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$2.04M ﹤0.01%
88,376
-179
-0.2% -$4.24K
CUBI icon
3136
Customers Bancorp
CUBI
$2.77B
$2.04M ﹤0.01%
71,810
-17,252
-19% -$515K
ETO
3137
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$515M
$2.04M ﹤0.01%
84,113
-5,888
-7% -$149K
HGV icon
3138
Hilton Grand Vacations
HGV
$3.61B
$2.03M ﹤0.01%
58,622
-8,301
-12% -$336K
SPLB icon
3139
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.16B
$2.03M ﹤0.01%
77,841
-2,787
-3% -$73.6K
EGO icon
3140
Eldorado Gold
EGO
$9.37B
$2.03M ﹤0.01%
408,786
-27,966
-6% -$144K
RRX icon
3141
Regal Rexnord
RRX
$11.9B
$2.03M ﹤0.01%
24,781
-8,923
-26% -$691K
IBP icon
3142
Installed Building Products
IBP
$6.52B
$2.02M ﹤0.01%
35,742
-13,592
-28% -$805K
BMY icon
3143
CALL
Bristol-Myers Squibb
BMY
$131B
$2.02M ﹤0.01%
36,500
-1,521,800
-98% -$82.2M
IHE icon
3144
iShares US Pharmaceuticals ETF
IHE
$1.64B
$2.02M ﹤0.01%
40,032
-56,289
-58% -$2.79M
LPLA icon
3145
LPL Financial
LPLA
$28.3B
$2.02M ﹤0.01%
30,799
-15,685
-34% -$1.03M
EPS icon
3146
WisdomTree US LargeCap Fund
EPS
$1.64B
$2.02M ﹤0.01%
65,728
+3,136
+5% +$96.5K
ESV
3147
DELISTED
Ensco Rowan plc
ESV
$2.02M ﹤0.01%
69,389
-2,714
-4% -$66.5K
AMRS
3148
CALL
DELISTED
Amyris Inc.
AMRS
$2.01M ﹤0.01%
+315,000
New +$1.89M
HRTX icon
3149
Heron Therapeutics
HRTX
$94.5M
$2.01M ﹤0.01%
51,776
-167,024
-76% -$5.32M
VZ icon
3150
CALL
Verizon
VZ
$195B
$2.01M ﹤0.01%
40,000
-172,100
-81% -$8.33M

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.